Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer

Clinical trial NCT02298959 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02298959
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Clinical Stage IV Cutaneous Melanoma AJCC v8 Metastatic Colorectal Carcinoma Metastatic Malignant Solid Neoplasm Metastatic Melanoma Metastatic Ovarian Carcinoma Metastatic Renal Cell Carcinoma Platinum-Resistant Ovarian Carcinoma Recurrent Melanoma Recurrent Renal Cell Carcinoma Refractory Melanoma Refractory Renal Cell Carcinoma Sarcoma

Start date: 2015-04-08
Primary completion: 2025-05-21
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.